Romero Feregrino Raúl, Pacheco Rosas Daniel O, Juárez Castillo Arantxa, Takashima Castro Melissa, Ruíz Ruíz Juan M
Pediatrics, Mexican Academy of Pediatrics, Mexico City, MEX.
Pediatrics/Infectious Diseases Service, Hospital de Pediatría Centro Médico Nacional (CMN) Siglo XXI, Mexico City, MEX.
Cureus. 2025 Aug 16;17(8):e90226. doi: 10.7759/cureus.90226. eCollection 2025 Aug.
is a Gram-negative, oxidase-positive, facultative anaerobic bacterium primarily recognized as a pathogen in fish. Its isolation in humans is rare and scarcely reported, particularly in cases of peritonitis. We present the case of a 16-year-old female patient with end-stage chronic kidney disease, recent renal graft rejection, and undergoing continuous ambulatory peritoneal dialysis, who presented with severe abdominal pain and cloudy peritoneal effluent. Fluid analysis revealed an elevated leukocyte count (15,022 cells/μL, including 13,330 polymorphonuclear cells). Empirical treatment with cefalotin and amikacin was initiated. Following the observation of short Gram-negative bacilli, the regimen was adjusted to intraperitoneal cefepime and amikacin. After 72 hours, the VITEK® 2 automated system identified with 98% probability. The patient showed clinical and laboratory improvement after 14 days of targeted therapy. Human infections caused by are exceptionally rare. This case highlights the importance of considering atypical pathogens in immunocompromised patients with peritonitis. Given the challenges in its identification, the use of automated or molecular diagnostic methods is recommended. Although no clear aquatic exposure was identified, the isolation of this microorganism supports the need for broad microbiological surveillance. Antimicrobial susceptibility profiles should be evaluated on a case-by-case basis.
是一种革兰氏阴性、氧化酶阳性、兼性厌氧细菌,主要被认为是鱼类中的病原体。它在人类中的分离很少见且报道稀少,尤其是在腹膜炎病例中。我们报告了一例16岁女性患者,患有终末期慢性肾病、近期肾移植排斥反应且正在接受持续非卧床腹膜透析,她出现了严重腹痛和浑浊的腹膜透析液。液体分析显示白细胞计数升高(15,022个细胞/μL,包括13,330个多形核细胞)。开始使用头孢噻吩和阿米卡星进行经验性治疗。在观察到短革兰氏阴性杆菌后,治疗方案调整为腹腔内使用头孢吡肟和阿米卡星。72小时后,VITEK® 2自动化系统以98%的概率鉴定出 。经过14天的靶向治疗,患者的临床和实验室指标有所改善。由 引起的人类感染极为罕见。该病例突出了在免疫功能低下的腹膜炎患者中考虑非典型病原体的重要性。鉴于其鉴定存在挑战,建议使用自动化或分子诊断方法。尽管未发现明确的水生接触史,但这种微生物的分离支持了进行广泛微生物监测的必要性。抗菌药物敏感性谱应根据具体病例进行评估。